Cleveland-Cliffs: What To Watch Before Q3 Earnings (Preview)

Cleveland-Cliffs’ Q2 EBITDA tripled to $286M, and the company guided to $575M of Q3 EBITDA. Government grants and contract wins support facility upgrades and potential CAPEX stability, while expiring loss-making contracts, higher-value steel products, and operational partnerships offer upside. The analyst maintains a Hold, citing execution that has lagged prior bullish expectations and slow debt reduction.

Analysis

The key distinction is EBITDA recovery versus debt capacity: a stronger quarterly run rate does not itself establish that cash is reaching the balance sheet. If working capital, interest, and upgrade spending absorb the improvement, equity may not receive the benefit implied by the headline EBITDA trajectory. Grants can ease project funding, but should not be treated as recurring operating cash flow or proof of faster deleveraging.

Over the next quarter, the Q3 guide is the near-term test; the more consequential 1–3 month signal is cash conversion and whether reported debt actually declines. Over 6–18 months, retiring loss-making contracts and shifting mix toward higher-value products could improve earnings quality, but only if replacement volume and plant utilization hold up. Contract exits could instead expose fixed-cost absorption risk. Operational partnerships and facility upgrades are execution claims until reflected in costs, reliability, and cash flow.

The contrarian risk is that a sharp EBITDA rebound invites investors to capitalize a cyclical peak before leverage has materially improved. Conversely, if contract resets and operating changes persist, a cautious stance could miss a more durable margin floor. Steel-price or input-cost reversals, outages, and weaker utilization could quickly undermine the improvement. No valuation, cash-flow, or market-expectations data are provided, so relative value and whether the guide is already priced in need verification.

Key Decisions for Investors

• Keep CLF at neutral/hold rather than chase the EBITDA rebound; do not equate the Q3 EBITDA guide with debt paydown.
• Use the next earnings update as a confirmation point: track free cash flow after capex and working-capital movements, net debt, and the realized benefit from contract repricing and product mix.
• Consider adding only after evidence of sustained cash generation and sequential debt reduction; the thesis is weakened if EBITDA meets guidance but net debt is flat or rises, or if utilization/margins deteriorate.
• Before any peer pair trade, verify relative valuation, leverage, product mix, and earnings sensitivity versus Nucor and Steel Dynamics; the supplied information alone does not establish an attractive spread.